Skip to main content
ZYME
NASDAQ Life Sciences

Zymeworks Posts $2.28 Per-Share Profit in Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$30.81
Mkt Cap
$2.188B
52W Low
$16.003
52W High
$31.49
52W Position info
93% above low
Off High info
2.2% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ZYME sits 93% above its 52-week low of $16.003.

Summary

Zymeworks reported third-quarter EPS of $2.28, a swing to profit that follows the FDA approval of Ziihera for first-line HER2-positive gastroesophageal adenocarcinoma in August and the $250M milestone payment from Jazz Pharmaceuticals it triggered. The quarter produced $256.5M in revenue and $173.7M in net income. The company also closed its $929M acquisition of Theravance Biopharma in September and issued 2026 revenue guidance of $278M at that time, and it has since raised its 2026 revenue and EBITDA guidance. The stock is trading near its 52-week high of $31.49, so the print lands with expectations already elevated.

At the time of this announcement, ZYME was trading at $30.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $16.00 to $31.49. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ZYME - Latest Insights

ZYME
Nov 09, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.81
Real-time Price: $31.00 info
Change: +$0.190 (+0.62%) info
Market Cap: $2.188B info
ZYME
Nov 09, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.81
Real-time Price: $31.00 info
Change: +$0.190 (+0.62%) info
Market Cap: $2.188B info
ZYME
Oct 24, 2026, 2:30 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $28.55
Real-time Price: $31.00 info
Change: +$2.45 (+9%) info
Market Cap: $2.188B info
ZYME
Oct 23, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.99
Real-time Price: $31.00 info
Change: +$2.01 (+7%) info
Market Cap: $2.188B info
ZYME
Sep 28, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $26.52
Real-time Price: $31.00 info
Change: +$4.48 (+17%) info
Market Cap: $2.188B info